Society
Injectable HIV Prevention Drug Faces Access Crisis Amid USAID Cuts
•Lenacapavir injectable PrEP offers 99% HIV prevention effectiveness, but USAID funding cuts threaten global access. Experts warn of widening health disparities.
1 August 2026